Apotex Research Private Limited Rivaroxaban Export Data — India (DGFT 2022–2026)

Name: Apotex Research Private Limited Rivaroxaban Export Records India — #6 Exporter, 54 Shipments, $2.3M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Rivaroxaban

India Pharmaceutical Trade Intelligence

$52.6M221 Suppliers115 CountriesHS 30049099

ExportsIndia → NETHERLANDS29.9%India → MALTA9.6%

ImportsGERMANY → India$34.1B CANADA → India$46.0K

#1 Supplier: MYLAN LABORATORIES #1 Buyer: MYLAN IRELAND

Apotex Research Private Limited — Rivaroxaban Exporter #6 | $2.3M Trade Value | TransData Nexus | TransData Nexus

Apotex Research Private Limited — Rivaroxaban Exporter Profile

Indian Pharmaceutical Exporter · #6 for Rivaroxaban · $2.3M export value · DGFT Verified

Apotex Research Private Limited is the #6 Indian exporter of Rivaroxaban with $2.3M in export value and 54 verified shipments. Apotex Research Private Limited holds a 4.3% market share in Rivaroxaban exports across 1 countries. The company exports 12 pharmaceutical products worth $56.3M across 4 therapeutic categories.

Apotex Research Private Limited — Rivaroxaban Export Profile: Buyers & Destinations

Apotex Research Private Limited Rivaroxaban export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Rivaroxaban?

Country	Value	Shipments	Share
NETHERLANDS	$11.4M	229	31.1%
MALTA	$5.0M	267	13.7%
CANADA	$3.2M	77	8.6%
BRAZIL	$2.6M	62	7.2%

Who Are the Top Buyers of Rivaroxaban from India?

Buyer	Country	Value	Orders
MYLAN IRELAND C/O ALLOGA RDC,	NETHERLANDS	$4.2M	83
PHARMADOX HEALTHCARE LTD	MALTA	$3.9M	194
APOTEX INC	CANADA	$1.3M	27
PHARMADOX HEALTHCARE LIMITED	MALTA	$1.1M	50
MYLAN IRELAND C/O ALLOGA RDC,.	NETHERLANDS	$911.1K	46
BIOLAB FARMA GENERICO	BRAZIL	$750.0K	15
GMP MANUFACTURING LTD	UNITED KINGDOM	$600.0K	12
TO THE PURCHASE MANAGER	ECUADOR	$450.0K	9
DEPO PACK SNC	ITALY	$250.0K	5
HEALTH CARE AGENCY, SEYCHELLES	SEYCHELLES	$150.0K	3

India's Rivaroxaban is purchased by 497 buyers worldwide. The top buyer is MYLAN IRELAND C/O ALLOGA RDC, (NETHERLANDS), followed by PHARMADOX HEALTHCARE LTD and APOTEX INC.

How Does Apotex Research Private Limited Compare to Nearest Rivaroxaban Exporters?

Exporters ranked immediately above and below #6 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
3	ZENTIVA PRIVATE LIMITED	$3.2M	148	2	$21.5K
5	MICRO LABS LIMITED	$2.4M	141	20	$16.9K
6	APOTEX RESEARCH PRIVATE LIMITED ★	$2.3M	54	1	$42.1K
7	TORRENT PHARMACEUTICALS LTD	$2.1M	59	5	$35.8K
9	INTAS PHARMACEUTICALS LIMITED	$1.6M	165	13	$9.9K

Apotex Research Private Limited ranks #6 among 221 Indian Rivaroxaban exporters. Average shipment value of $42.1K compared to the market average of $166.0K. The closest competitors by value are ZENTIVA PRIVATE LIMITED and MICRO LABS LIMITED.

Which Indian Ports Ship Rivaroxaban Exports?

Port	Shipments	% Share
SAHAR AIR	1,144	21.3%
DELHI AIR CARGO ACC (INDEL4)	985	18.4%
DELHI AIR	659	12.3%
SAHAR AIR CARGO ACC (INBOM4)	635	11.8%
Bombay Air	197	3.7%
NHAVA SHEVA SEA (INNSA1)	164	3.1%
Delhi Air	133	2.5%
HYDERABAD AIR	110	2.1%

Geopolitical & Trade Policy Impact on Apotex Research Private Limited's Rivaroxaban Exports

The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Apotex Research Private Limited. The Israel-Iran conflict has led to increased tensions in the Red Sea, resulting in higher shipping costs and potential delays for goods transiting this critical route. Such disruptions can impact the timely delivery of pharmaceutical products to key markets, necessitating strategic adjustments in logistics and supply chain management.

Conversely, ongoing trade tensions between the United States and China have prompted the U.S. to diversify its import sources, creating opportunities for Indian pharmaceutical companies to capture a larger share of the American market. Apotex Research, with its established export portfolio, is well-positioned to leverage this shift.

In the European Union, stringent regulatory changes, such as the Falsified Medicines Directive, impose additional compliance requirements on exporters. Indian pharmaceutical companies must invest in robust quality assurance systems to meet these standards. Apotex Research's adherence to Good Manufacturing Practices (GMP) and its commitment to quality position it favorably to navigate these regulatory landscapes and maintain its foothold in the EU market.

Apotex Research Private Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for pharmaceutical exporters. Apotex Research Private Limited's operations are aligned with the stringent requirements set forth by agencies such as the U.S. Food and Drug Administration (FDA), the World Health Organization (WHO), and the European Medicines Agency (EMA). The company's commitment to maintaining high-quality manufacturing practices ensures its products meet global safety and efficacy standards.

The evolving regulatory environment necessitates continuous investment in quality control and assurance processes. Apotex Research's proactive approach to compliance not only facilitates market access but also enhances its reputation as a reliable supplier in the global pharmaceutical industry.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Rivaroxaban shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Apotex Research Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 115+ countries, 497+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Rivaroxaban

Rivaroxaban

Apotex Research Private Limited — Rivaroxaban Exporter Profile

Apotex Research Private Limited — Rivaroxaban Export Profile: Buyers & Destinations

Where Does India Export Rivaroxaban?

Who Are the Top Buyers of Rivaroxaban from India?

What Is India's Total Rivaroxaban Export Value and How Much Does Apotex Research Private Limited Contribute?

What Is the Average Shipment Value for Apotex Research Private Limited's Rivaroxaban Exports?

How Does Apotex Research Private Limited Compare to Other Indian Rivaroxaban Exporters?

Regulatory Requirements: Exporting Rivaroxaban to Key Markets

Canada — HC

Brazil — ANVISA

How Does Apotex Research Private Limited Compare to Nearest Rivaroxaban Exporters?

Which Indian Ports Ship Rivaroxaban Exports?

What Other Cardiovascular Products Does Apotex Research Private Limited Export?

Geopolitical & Trade Policy Impact on Apotex Research Private Limited's Rivaroxaban Exports

Apotex Research Private Limited — Regulatory Compliance & Quality Standards

About Apotex Research Private Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Rivaroxaban Export Data from Apotex Research Private Limited

Rivaroxaban Stats

Company Overview

Top Products by Apotex Research Private Limited

Related Analysis

Need Detailed Export Data?

Data Source